Myocardial Inflammation-Are We There Yet?
- PMID: 25705323
- PMCID: PMC4330458
- DOI: 10.1007/s12410-015-9320-6
Myocardial Inflammation-Are We There Yet?
Abstract
Several exogenous or endogenous factors can lead to inflammatory heart disease. Beside infectious myocarditis, other systemic inflammatory disorders such as sarcoidosis, systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Churg-Strauss syndrome, and rheumatoid arthritis can affect the myocardium. Myocardial inflammation may have a major impact on the outcome of these patients, resulting in sudden cardiac death, severe arrhythmias, or end-stage heart failure. The current gold standard for definite confirmation of inflammatory heart disease is endomyocardial biopsy (EMB), but is invasive and suffers low sensitivity and specificity due to sampling errors. Thus, non-invasive methods for detecting the extent and changes over time of the inflammatory myocardial disease are needed. Cardiac magnetic resonance (CMR) is such a non-invasive method. We will describe and discuss different approaches for CMR assessment of inflammatory myocardial disease including early gadolinium enhancement (EGE), T2-weighted imaging, late gadolinium enhancement (LGE), the newer mapping proton relaxation techniques (T1 pre-contrast, T1 post-contrast, T2 mapping), and the hybrid PET/MRI technique.
Keywords: Cardiovascular magnetic resonance; Edema; Gadolinium; Mapping; Myocardial inflammation; Tissue characterization.
Conflict of interest statement
Simon Greulich, Vanessa M Ferreira, Erica Dall’Armellina, and Heiko Mahrholdt declare that they have no conflict of interest.
Figures




Similar articles
-
Multiparametric Cardiovascular Magnetic Resonance in Acute Myocarditis: Comparison of 2009 and 2018 Lake Louise Criteria With Endomyocardial Biopsy Confirmation.Front Cardiovasc Med. 2021 Oct 12;8:739892. doi: 10.3389/fcvm.2021.739892. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34712710 Free PMC article.
-
Early myocardial gadolinium enhancement in patients with myocarditis: Validation of "Lake Louise consensus" criteria using a single bolus of 0.1mmol/Kg of a high relaxivity gadolinium-based contrast agent.Eur J Radiol. 2017 Oct;95:89-95. doi: 10.1016/j.ejrad.2017.07.008. Epub 2017 Jul 27. Eur J Radiol. 2017. PMID: 28987703
-
The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis.Lupus. 2013 Jan;22(1):34-43. doi: 10.1177/0961203312462265. Epub 2012 Oct 3. Lupus. 2013. PMID: 23035042
-
Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases.Int J Cardiovasc Imaging. 2018 Jan;34(1):35-54. doi: 10.1007/s10554-017-1063-9. Epub 2017 Jan 27. Int J Cardiovasc Imaging. 2018. PMID: 28130644 Free PMC article. Review.
-
Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis.Autoimmun Rev. 2012 Dec;12(2):305-12. doi: 10.1016/j.autrev.2012.05.005. Epub 2012 May 19. Autoimmun Rev. 2012. PMID: 22617620 Review.
Cited by
-
CMR findings in patients referred for suspected myocarditis following mRNA-based COVID vaccination compared with pre-COVID myocarditis referrals: A single-centre observational study.Int J Cardiol Heart Vasc. 2022 Nov 5;43:101142. doi: 10.1016/j.ijcha.2022.101142. eCollection 2022 Dec. Int J Cardiol Heart Vasc. 2022. PMID: 36389264 Free PMC article.
-
Myocardial T1 maps reflect histological findings in acute and chronic stages of myocarditis in a rat model.J Cardiovasc Magn Reson. 2016 Apr 16;18:19. doi: 10.1186/s12968-016-0241-6. J Cardiovasc Magn Reson. 2016. PMID: 27084492 Free PMC article.
-
Recent advances in cardiac magnetic resonance.F1000Res. 2016 Sep 7;5:F1000 Faculty Rev-2253. doi: 10.12688/f1000research.8383.1. eCollection 2016. F1000Res. 2016. PMID: 27635240 Free PMC article. Review.
-
T2 mapping and T2* imaging in heart failure.Heart Fail Rev. 2017 Jul;22(4):431-440. doi: 10.1007/s10741-017-9616-5. Heart Fail Rev. 2017. PMID: 28497231 Free PMC article. Review.
-
Using Multiparametric Cardiac Magnetic Resonance to Phenotype and Differentiate Biopsy-Proven Chronic from Healed Myocarditis and Dilated Cardiomyopathy.J Clin Med. 2022 Aug 28;11(17):5047. doi: 10.3390/jcm11175047. J Clin Med. 2022. PMID: 36078976 Free PMC article.
References
-
- Grun S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012;59(18):1604–15. doi:10.1016/j.jacc.2012.01.007. Prognostic role of LGE in patients with biopsy-proven viral myocarditis: Presence of LGE is the best independent predictor of all-cause mortality and of cardiac mortality. - PubMed
-
- Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–2648. doi: 10.1093/eurheartj/eht210. - DOI - PubMed
-
- Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45(11):1815–1822. doi: 10.1016/j.jacc.2004.11.069. - DOI - PubMed
-
- Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Choudhury RP, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2012;14:42. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources